Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

Private letters reveal Syngenta and Bayer's furious lobbying against bee pesticide ban

  • Dansk
  • Nederlands
  • English
  • Suomi
  • Français
  • Deutsch
  • Ελληνικά
  • Italiano
  • Bokmål
  • Polski
  • Portuguese
  • Română
  • Slovenščina
  • Español
  • Svenska

Biotech and pesticides giants Syngenta and Bayer are waging an all-out lobbying war against an upcoming vote on a limited ban on three of their pesticides1. The European Commission (EC) proposed this ban following very critical conclusions by the European Food Safety Authority (EFSA) based on new scientific evidence. Corporate Europe Observatory (CEO) had access to private letters and emails sent by these two companies and allied lobby groups to the EC as well as EFSA, which displayed their strong-arm tactics to try to avoid the ban.

CEO's report “Pesticides against Pollinators”2 exposes their lobbying strategy including attempts to change the EFSA press release. Syngenta had access to this document before its publication and immediately sent EFSA an extremely aggressive letter demanding the text be changed and issuing legal threats against the agency and its director.

Their tactics to prevent a ban against their products also include:

  • use of for-hire scientists to defend their point of view and spread doubt about scientific studies' evidence about the pesticides' effect on bees (including a re-analysis of EFSA's conclusions);

  • misinformation and scaremongering (making unsubstantiated economic and scientific claims) ;

  • attempts to impress the European Commission with boasts about science being on their side, and their powerful political connections with for example Obama and Hollande;

  • putting the blame for possible damage on bees on farmers mishandling their pesticides.

The EC has already put the ban to the vote within the Standing Committee on the Food Chain and Animal Health last March 15, but no qualified majority could be found either for or against the proposal. With the next round of vote in Appeal Committee expected for end of April or early May, corporate lobbying on Member States is intensifying, with large public campaigns in the media in several EU countries, including the UK and Germany3.

CEO researcher and campaigner David Sanchez said: “Although publicly calling for science-based decisions, industry's strategy is to attack scientists when science is not on their side. Bee health is crucial for European´s environment, agriculture and economy, while neonicotinoid pesticides are a huge business only for a few large companies. National governments will have to choose between protecting corporate interests and surrender to their lobby campaign, or taking real action to face one of the main environmental problems Europe is facing.”

CEO researcher and campaigner Martin Pigeon said: “The brutal tactics used by industry against EFSA show that this agency remains an absolutely key element within the EU's food safety system. While it courageously resisted industry pressure on this very symbolic dossier, it remains too weak and under-resourced to sustain this level of independence from industry in the long run. The European Parliament must help the agency build on this important precedent when it votes its budget discharge in plenary vote next week”.

 

A crusade for big business-friendly deregulation, waged during José Manuel Barroso's Presidency of the European Commission, shows no signs of stopping. This neoliberal push to weaken or block new legislation appears likely to expand with Jean-Claude Juncker's new Commission team.
Our correspondence with Pr. Anne Glover, the current Chief Scientific Adviser to the President of the European Commission (CSA), on her role in the European Commission's review of endocrine disrupting chemicals shows how the very existence of her position was used by business-friendly interests to convey key messages to the top of the European Commission's hierarchy, playing a determining role in the massive delay now inflicted to the European Commission's handling of this important public health regulation. We ask that the CSA position is not renewed in the new Juncker Commission.
Will EFSA become more transparent, and to lobbyists or scientists? After its public consultation on its draft transparency policy, the Authority must now choose.
Corporate Europe Observatory (CEO) today criticised the plenary vote of MEPs to approve the Jean-Claude Juncker Commission.

Corporate Europe Forum